Chicago Atlantic Real Estate Finance, Inc. (REFI) closed the last trading session at $12.44, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $16.5 indicates a 32.6% upside potential.The average comprises four short-term price targets ranging from a low of $12.00 to a high of $20.00, with a standard deviation of $4.12. While the lowest estimate indicates a decline of 3. ...

Shares of Elicio Therapeutics (ELTX) have gained 41.8% over the past four weeks to close the last trading session at $12.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.33 indicates a potential upside of 42.3%.The mean estimate comprises three short-term price targets with a standard deviation of $0.58. While the lowest estimate of $17.00 indicates a 39.6% increase from ...

Quick Read T-Mobile US (TMUS) added 3.3 million postpaid phone net additions in 2025 (industry-leading), generated $17.995 billion in free cash flow (up 80.27% year-over-year), and guided for $37.0B to $37.5B Core Adjusted EBITDA in 2026 representing 10% year-over-year growth. Citi analyst Michael Rollins raised his price target to $225 from $220, arguing the stock trades at a 0.8 PEG ratio that underprices earnings growth and deserves multiple expansion. T-Mobile’s industry-leading subscriber growth a ...

Core Viewpoint - Guidewire Software (GWRE) has shown a significant price increase of 26.4% over the past four weeks, with analysts projecting a mean price target of $236.77, indicating a potential upside of 47.5% from the current price of $160.57 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $43.16, suggesting variability in analyst predictions. The lowest estimate is $160.00, indicating a slight decline, while the highest estimate is $300.00, reflecting an optimistic potential increase of 86.8% [2] - Analysts' price targets can often mislead investors, as empirical research indicates that these targets rarely predict actual stock price movements accurately [7][10] - A low standard deviation among price targets indicates a strong consensus among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have shown growing optimism regarding GWRE's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher. This trend is correlated with near-term stock price movements [11] - The Zacks Consensus Estimate for the current year has increased by 42.2% over the past month, with six estimates revised upward and no negative revisions [12] - GWRE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside in the near term [13]

Core Viewpoint - Anterix (ATEX) has shown a significant price increase of 16.1% over the past four weeks, with a mean price target of $55.33 indicating a potential upside of 49.5% from the current price of $37.02 [1] Price Targets and Analyst Consensus - The average price target for ATEX ranges from a low of $44.00 to a high of $72.00, with a standard deviation of $14.74, suggesting variability in analyst estimates [2] - The lowest estimate indicates an 18.9% increase, while the highest suggests a 94.5% upside [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding ATEX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 13.6%, with one estimate moving higher and no negative revisions [12] - ATEX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][7] - Analysts often set optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately predict stock price movements [10]

Core Viewpoint - Descartes Systems (DSGX) has shown a significant price increase of 11.2% over the past four weeks, with analysts projecting a mean price target of $109.42, indicating a potential upside of 52% from the current price of $71.98 [1] Price Targets and Estimates - The mean estimate consists of 12 short-term price targets with a standard deviation of $12.64, where the lowest estimate is $90.00 (25% increase) and the highest is $126.00 (75.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about DSGX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, two earnings estimates have increased, leading to a 3.4% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - DSGX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

Stantec (STN) closed the last trading session at $88.85, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $120.63 indicates a 35.8% upside potential.The average comprises 11 short-term price targets ranging from a low of $106.86 to a high of $129.94, with a standard deviation of $8.01. While the lowest estimate indicates an increase of 20.3% from the current price level ...

Core Viewpoint - Jones Lang LaSalle (JLL) shares have increased by 5% recently, closing at $294.19, with analysts suggesting a potential upside of 32.9% based on a mean price target of $391.11 [1] Price Targets - The average price target from nine analysts ranges from a low of $320.00 to a high of $431.00, with a standard deviation of $36.79, indicating variability in estimates [2] - The lowest estimate suggests an 8.8% increase, while the highest indicates a 46.5% upside [2] Analyst Sentiment - Analysts show strong agreement in revising JLL's earnings estimates higher, which historically correlates with stock price movements [4][11] - Over the past 30 days, three earnings estimates have been revised upward, leading to a 5.7% increase in the Zacks Consensus Estimate [12] Zacks Rank - JLL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of JLL's potential gains, it does provide a useful guide for the direction of price movement [14]

Group 1 - The stock of Remitly Global, Inc. (RELY) closed at $16.98, reflecting a 28.2% increase over the past four weeks, with a mean price target of $21.94 indicating a potential upside of 29.2% [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $3.05, where the lowest estimate is $18.00 (6% increase) and the highest is $28.00 (64.9% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with two estimates moving up in the last 30 days and no negative revisions, leading to a 50% increase in the Zacks Consensus Estimate for the current year [12][13] Group 2 - The Zacks Rank for RELY is 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target is a commonly referenced metric, it should not be the sole basis for investment decisions due to the questionable reliability of analysts in setting these targets [3][10] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]

Core Viewpoint - The worst of the war-related market turmoil may be over, making it a potentially good time to invest in Nasdaq, Inc. (NDAQ) stock, with strategies including shorting out-of-the-money puts and buying in-the-money calls for longer durations [1]. Price Targets - NDAQ is currently trading at $88.17, which is an increase from a low of $79.01 on February 12, indicating potential for further growth [1]. - A valuation of $95.95 per share is suggested based on strong free cash flow (FCF) and margins, representing an 8.8% upside from the current price [3]. - Other analysts have set higher price targets, with an average of $108.53 from 17 analysts, indicating a 23% upside, and Barchart's mean analyst survey shows a target of $111.88, which is 27% higher than the current price [4]. Investment Strategy - Selling short out-of-the-money (OTM) puts is recommended as a strategy to capitalize on the current low price of NDAQ, allowing investors to earn income while waiting for a lower buy-in point [5]. - A previous recommendation involved shorting the $80.00 strike price put option, which had a premium of $1.60, yielding 2.0% over 38 days. The premium has since decreased to 43 cents, indicating that much of the income from this strategy has already been realized [6]. - It is suggested to roll over this strategy by closing the previous position and initiating a new short-put play, with the April 17, 2026, expiry showing a $82.50 strike price put contract with a midpoint premium of $1.65, offering a similar yield of 2.0% [7][9].